ORIC Pharmaceuticals, Inc. (ORIC) vs Tyra Biosciences, Inc. (TYRA)
A side-by-side comparison of ORIC Pharmaceuticals, Inc. and Tyra Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ORIC
ORIC Pharmaceuticals, Inc.
$11.98HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TYRA
Tyra Biosciences, Inc.
$20.24HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ORIC vs TYRA
growth of $100 · dividends reinvested · last 5yORIC -50.0% (-12.9%/yr)TYRA -19.5% (-4.2%/yr)TYRA compounded faster over this window
ORIC TYRA
ORIC vs TYRA: by the numbers
- •ORIC is the larger company ($1.24B vs $1.21B market cap).
Metrics side by side
Valuation
| Metric | ORIC | TYRA |
|---|---|---|
| P/B ratio | 3.25 | 3.41 |
Profitability
| Metric | ORIC | TYRA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -36.81% | -42.01% |
| ROIC | -40.32% | -44.73% |
Growth (annualized)
| Metric | ORIC | TYRA |
|---|---|---|
| Total return CAGR (5Y) | -8.73% | 9.23% |
Frequently asked
- How have ORIC and TYRA total returns compared?
- Over the past 5 years, ORIC delivered -8.73% and TYRA delivered 9.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.